Internal Medicine News - Wellbutrin XL
July 15, 2006 -- Wellbutrin XL (bupropion extended release, GlaxoSmithKline) An antidepressant for preventing seasonal major depressive episodes in people with...
Skin & Allergy News - Cubicin, Wellbutrin XL
August 1, 2006 -- Cubicin (daptomycin for injection, Cubist Pharmaceuticals) A cyclic lipopeptide antibiotic--a new antibiotic class--approved for treating patients...
Business Wire - Teva Announces Launch of Generic Wellbutrin XL® Tablets, 150 mg
May 30, 2008 -- JERUSALEM, Israel -- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has begun commercially shipping Bupropion...
Business Wire - Anchen Announces Approval of Generic Version of Wellbutrin XL
December 15, 2006 -- IRVINE, Calif. -- Anchen Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has granted final approval for the...
Chain Drug Review - GSK receives FDA O.K. for Wellbutrin XL and Avandamet
July 24, 2006 -- The Food and Drug Administration has approved GlaxoSmithKline PLC's Wellbutrin XL for preventing seasonal depression. The agency says the product is...
Market Wire - Actavis receives approval of generic Wellbutrin XL(R) 300mg in the United States
August 19, 2008 -- Reykjavik, Iceland, 19 August 2008 -- Actavis Group, the international generic pharmaceuticals company, todayannounced thatit has received approval...
Business Wire - Biovail Comments on Wellbutrin XL Global Marketing Status
December 9, 2003 -- Business Editors TORONTO--(BUSINESS WIRE)--Dec. 9, 2003 Biovail Corporation (NYSE:BVF)(TSX:BVF) confirmed today that GlaxoSmithKline (GSK) has...
Business Wire - Biovail Confirms Wellbutrin XL Shipment Recovery
October 8, 2003 -- Business Editors/Health/Medical Writers TORONTO--(BUSINESS WIRE)--Oct. 8, 2003 Biovail Corporation (NYSE:BVF)(TSX:BVF) today confirmed that it...
Pharmaceutical Processing - Andrx files Wellbutrin XL patent suit.(Noted)
January 1, 2006 -- Andrx files Wellbutrin XL patent suit: Andrx filed a patent infringement suit against GlaxoSmithKline in Miami federal court Dec. 20 alleging that...
Business Wire - Biovail Announces Receipt of an Approvable Letter for Wellbutrin XL
June 26, 2003 -- Business Editors/Health/Medical Writers TORONTO--(BUSINESS WIRE)--June 26, 2003 Biovail Corporation (NYSE:BVF) (TSX:BVF) announced today that the...
